Emanuel Marques (E Marques)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Hidradenitis Suppurativa

Top Venues

Journal of the European Academy of Dermatology and Venereology : JEADV

International journal of dermatology

The Journal of dermatological treatment

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Marek Pásek, Emanuel Marques, Jiří Švec, Petr Arenberger, Monika Arenbergerova
Observational study with lenvatinib and pembrolizumab in heavily pretreated patients with metastatic melanoma. International journal of dermatology (2024)
Alžběta Smetanová, Marek Pásek, Emanuel Marques, Jana Vránová, Petr Arenberger, Alena Machovcová, Zuzana Horáčková, Monika Arenbergerova, null null
Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti-TNF-alpha-Results from a 12-year multicentric observational prospective study. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Marek Pásek, Emanuel Marques, Jiří Švec, Petr Arenberger, Monika Arenbergerova
Observational study with lenvatinib and pembrolizumab in heavily pretreated patients with metastatic melanoma. International journal of dermatology 63 (9) (2024)
Alžběta Smetanová, Marek Pásek, Emanuel Marques, Jana Vránová, Petr Arenberger, Alena Machovcová, Zuzana Horáčková, Monika Arenbergerova, null null
Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti-TNF-alpha-Results from a 12-year multicentric observational prospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Alžběta Smetanová, Marek Pásek, Emanuel Marques, Jana Vránová, Petr Arenberger, Alena Machovcová, Zuzana Horáčková, Monika Arenbergerova, null null
Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti-TNF-alpha-Results from a 12-year multicentric observational prospective study. Journal of the European Academy of Dermatology and Venereology : JEADV 38 (9) (2024)
Monika Arenbergerova, Spyridon Gkalpakiotis, Emanuel Marques, P Arenberger, R A Dahmen, A Smetanova
Corticosteroid rescue therapy in relapsing hidradenitis suppurativa treated with adalimumab. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (6) (2021)
Emanuel Marques, P Arenberger, A Smetanová, S Gkalpakiotis, D Zimová, M Arenbergerová
Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha. The British journal of dermatology 184 (5) (2021)
Emanuel Marques, Zoltán Paluch, Petr Boháč, Ondřej Slanař, Jaromír Běláček, Jana Hercogová
Epidemiology of moderate-to-severe psoriasis: a comparison between psoriasis patients treated with biological agents, conventional systemic drugs and topical agents. The Journal of dermatological treatment (2020)